Microsoft's (NASDAQ:MSFT) upcoming earnings report could be mixed due to new metrics published in August that are not yet ...

We recently compiled a list of the 20 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

In a report released today, Matthew Clark from Piper Sandler maintained a Hold rating on Washington Federal (WAFD – Research Report), ...

On Friday, Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.34 which represents a slight increase of $0.01 or 0.75% from the prior close of $1.33. The stock opened at $1.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.04% of ...

In a reminder that stretched valuations make for poor timing signals, Piper Sandler strategist Michael Kantrowitz observed in ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Supernus Pharmaceuticals (SUPN – Research ...

Jimmy Dunne, the Wall Street deal maker who helped architect the PGA Tour’s controversial deal with the Saudi Arabian Public ...

Piper Sandler believes Microsoft (NASDAQ: MSFT)'s upcoming earnings report on October 30 could be "mixed," citing challenges ...

"Stocks can remain at rich valuations as long as a 'fear' catalyst doesn't arise from" interest rates, employment, or ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...